PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Conjugated oestrogens with medroxyprogesterone - Menopausal disorders

PAD Profile : Conjugated oestrogens with medroxyprogesterone - Menopausal disorders

Keywords :
hormone replacement therapy, HRT, menopause, continuous combined therapy, menopausal symptoms
Brand Names Include :
Premique Low Dose

Traffic Light Status

Status 1 of 1.

Status :
Non Formulary
Important
Formulations :
  • Modified release tablets
Important Information :
Premique Low Dose - no longer recommended. Switch to a newer, lower risk formulation.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

Additional Documents

No additional documents returned.

Committee Recommendations

No committee recommendations returned.

Associated BNF Codes

No BNF codes returned.

This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More